TFF Pharmaceuticals Inc. (TFFP) Tops Q3 EPS by 3c

TFF Pharmaceuticals Inc. (NASDAQ: TFFP) reported Q3 EPS of ($0.29), $0.03 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $90 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on TFF Pharmaceuticals Inc. (TFFP) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• Bernstein SocGen on StandardAero Inc (SARO): ' Solid revenues, but short-term margin issues'
• TORM appoints Jann Brown to its board of directors